Literature DB >> 18839274

Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.

Athanasios Papadopoulos1, George Ntaios2,3, Georgia Kaiafa1, Fotios Girtovitis1, Zoi Saouli1, Zisis Kontoninas1, Michael D Diamantidis1, Christos Savopoulos1, Apostolos Hatzitolios1.   

Abstract

Veno-occlusive disease (VOD) of the liver, also termed as sinusoidal obstruction syndrome, constitutes a well-known complication of high-dose cytoreductive chemotherapy prior to allogeneic or autologous bone marrow transplantation and is associated with the intensity of treatment [1]. On the contrary, there is only one report of VOD during induction therapy for acute lymphoblastic leukemia in a patient with Marfan syndrome, who was successfully treated with defibrotide [2]. In this article, we present the first fatal case of VOD during induction therapy for acute lymphoblastic leukemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18839274     DOI: 10.1007/s12185-008-0172-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  6 in total

1.  Venoocclusive disease of the liver following bone marrow transplantation.

Authors:  R J Jones; K S Lee; W E Beschorner; V G Vogel; L B Grochow; H G Braine; G B Vogelsang; L L Sensenbrenner; G W Santos; R Saral
Journal:  Transplantation       Date:  1987-12       Impact factor: 4.939

2.  Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase.

Authors:  Michael Bodmer; Michael Sulz; Sylvia Stadlmann; Armin Droll; Luigi Terracciano; Stephan Krähenbühl
Journal:  Digestion       Date:  2006-09-19       Impact factor: 3.216

3.  Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide.

Authors:  Osnat Bairey; Ilia Kirgner; Moshe Yakobi; Ashraf Hamdan; Ziv Ben-Ari; Mati Shaklai
Journal:  Am J Hematol       Date:  2002-04       Impact factor: 10.047

4.  Hepatic veno-occlusive disease after tandem autologous stem cell transplantation conditioned by melphalan.

Authors:  Sana Intidhar Labidi; Catherine Sebban; Hervé Ghesquières; Emmanuele Virelizier Nicolas; Pierre Biron
Journal:  Int J Hematol       Date:  2008-08-12       Impact factor: 2.490

5.  Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors.

Authors:  G B McDonald; P Sharma; D E Matthews; H M Shulman; E D Thomas
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

6.  Veno-occlusive disease in a male patient with Marfan syndrome and common acute lymphoblastic leukemia during induction therapy.

Authors:  D M Kraemer; J Waschke; V Kunzmann; M Wilhelm
Journal:  Ann Hematol       Date:  2003-05-22       Impact factor: 3.673

  6 in total
  2 in total

1.  Fatal hepatic sinusoidal obstruction syndrome in a child with primary CNS lymphoma during induction therapy.

Authors:  Shohei Yamamoto; Kousuke Akiyama; Nobuo Oyama; Mayumi Hayashi; Yoko Fujimoto; Hirokazu Ikeda; Keiichi Isoyama
Journal:  Int J Hematol       Date:  2012-06-27       Impact factor: 2.490

2.  Association between malignancies and Marfan syndrome: a population-based, nested case-control study in Taiwan.

Authors:  Chin-Wang Hsu; Jen-Chun Wang; Wen-I Liao; Wu-Chien Chien; Chi-Hsiang Chung; Chang-Huei Tsao; Yung-Fu Wu; Min-Tser Liao; Shih-Hung Tsai
Journal:  BMJ Open       Date:  2017-10-16       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.